Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sarah Hubbard

Optometrist Chesterfield, MO Doctor of Optometry

NPI 1063467025 CMS profile 275569

17249 Chesterfield Airport Rd, Chesterfield, MO 63005

Open in the dashboard

General payments

$91,068

374 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sarah Hubbard of Chesterfield, MO is reported in the CMS Open Payments database as having received $91,068 across 374 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $53,027 155
2024 General $35,096 111
2023 General $1,056 30
2022 General $534 24
2021 General $615 28
2020 General $187 10
2019 General $554 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sarah Hubbard
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Sarah Hubbard were reported at $53,027. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Sarah Hubbard Optometrist median Middle half National median
2019 $554 $159 $67–$371 $163
2020 $187 $72 $29–$165 $114
2021 $615 $125 $46–$292 $132
2022 $534 $162 $66–$374 $149
2023 $1,056 $177 $72–$406 $160
2024 $35,096 $188 $77–$427 $164
2025 $53,027 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Bausch & Lomb Americas Inc. $87,500 253 payments
  2. Bausch & Lomb, a division of Bausch Health US, LLC $801 28 payments
  3. Sun Pharmaceutical Industries Inc. $447 16 payments
  4. Amgen Inc. $346 3 payments
  5. Johnson & Johnson Surgical Vision, Inc. $256 2 payments
  6. Novartis Pharmaceuticals Corporation $232 10 payments
  7. Glaukos Corporation $230 8 payments
  8. Dompe US, Inc. $216 5 payments
  9. Allergan Inc. $169 11 payments
  10. Harrow Eye, LLC $149 6 payments
  11. Other $723 32 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for a medical education program $68,200 29 payments
  2. Travel and Lodging $12,244 109 payments
  3. Food and Beverage $8,999 233 payments
  4. Consulting Fee $1,600 1 payment
  5. Gift $19 1 payment
  6. Education $5 1 payment
Products named General payments · program years 2019–2025
  1. MIEBO $84,393 221 payments
  2. XIIDRA Ophthalmology $50,558 134 payments
  3. XIIDRA Ophthalmology $32,181 93 payments
  4. LOTEMAX SM $804 29 payments
  5. Cequa $447 16 payments
  6. BLINK NUTRITEARS $400 2 payments
  7. TEPEZZA $346 3 payments
  8. VYZULTA $335 7 payments
  9. OXERVATE $216 5 payments
  10. INFUSE $199 7 payments
  11. Other $1,814 77 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

374 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record